0,9% saline

DRUG4 trials

Sponsors

Federal University of Bahia, Regional Hospital Holstebro, Attikon Hospital, University of Sao Paulo

Conditions

AllodyniaCardiopathyCoronary Artery DiseaseHeadacheNephrotoxicityPainPostoperative PainValve Heart Disease

Phase 3

Botulinum Toxin Type A in Treatment of Cranial Allodynia in Patients With Headache

CompletedNCT01357798

Federal University of BahiaAllodynia, Headache

Start: 2010-12-31Target: 40Updated: 2011-05-23

Phase 4

0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis

Regional Hospital HolstebroNephrotoxicity

Start: 2015-03-31End: 2016-02-29Target: 40Updated: 2015-08-19

Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery

University of Sao PauloCardiopathy, Coronary Artery Disease, Pain +1

Start: 2021-10-07End: 2023-10-10Target: 102Updated: 2021-10-20

Unknown Phase

Dexmedetomidine Wound Infiltration in Cesarean Section

RecruitingNCT03382938

Attikon HospitalPostoperative Pain

Start: 2019-08-23End: 2026-11-20Target: 100Updated: 2025-03-19

Related Papers

Effect of 0.9% NaCl compared to plasma-lyte on biomarkers of kidney injury, sodium excretion and tubular transport proteins in patients undergoing primary uncemented hip replacement – a randomized trial

BMC Nephrology2021-03-267 citations